Ben Scruggs
InvestorPrincipal at Hatteras Venture Partners
Raleigh-Durham / Southeast US
Writes $100K β $5M checks Β· typically $1.5M
About
Ben Scruggs is CEO of Altis Biosystems, where he oversees commercialization of a human intestinal platform derived from stem cells for applications in ADME assessment, toxicity, inflammation, metabolism, and epithelial repair. He is also a Partner at Hatteras Venture Partners, investing in biotechnology and life science tools companies and advising on strategy and commercialization. Scruggs serves on the boards of IMMvention Therapeutix and Veralox Therapeutics.
Experience
- Hatteras Venture PartnersPartnercurrent2025 β present
- Hatteras Venture PartnersPrincipal2021 β 2024
- Hatteras Venture PartnersAssociate2017 β 2021
- Hatteras Venture PartnersAnalyst2017Raleigh-Durham-Chapel Hill Area
- Hatteras Venture PartnersHatteras Fellow2016Raleigh-Durham-Chapel Hill Area
- Altis BiosystemsChairman & CEOcurrent2023 β present
- VERALOX TherapeuticsBoard Membercurrent2021 β present
- IMMvention Therapeutix, Inc.Board Membercurrent2020 β present
- L2 VenturesManagercurrent2020 β present
- Tune TherapeuticsSr. Director, Strategic Initiatives2022 β 2023
- National Institute of Environmental Health Sciences (NIEHS)Postdoctoral Fellow2013 β 2016
- Washington University School of MedicinePh.D. Candidate in Molecular Cell Biology2006 β 2012
- Vanderbilt University Medical CenterUndergraduate research2003 β 2006
- National Institutes of HealthSummer Research Intern2004 β 2005
- LSU Health Sciences CenterSummer research intern2003
- LSU Health Sciences CenterScience and Medicine Academic Research Training Program2001 β 2002
Education
- Washington University School of Medicine in St. LouisPhD, Molecular Cell Biology2006 β 2012
- Vanderbilt UniversityB.E., Biomedical Engineering2002 β 2006
- HBX | Harvard Business SchoolCORe: Credential of Readiness2015
Skills & more
+11 more
Venture CapitalBoard GovernanceFundraisingBiotechnologyDue DiligenceMicroscopyImmunohistochemistryRNA biologyGene ExpressionTranscriptional RegulationLife SciencesFrom Ben's professional profile.
Colleagues at Hatteras Venture Partners
Network5
Investors connected to Ben in public investor directories β a warm-intro map.
Frequently asked questions
- Where does Ben Scruggs work?
- Ben Scruggs is Principal at Hatteras Venture Partners.
- What check size does Ben Scruggs write?
- Ben Scruggs typically writes checks of $100K β $5M.
Founder mafias
Vanderbilt University mafia32
Also came through, then founded or led a company.
+ 25 more
Harvard Business School Online mafia26
Also came through, then founded or led a company.
+ 19 more
Washington University School of Medicine in St. Louis mafia6
Also came through, then founded or led a company.
Hatteras Venture Partners mafia4
Also came through, then founded or led a company.
Same school
Also attended Washington University School of Medicine in St. Louis11
+ 5 more
Also attended Vanderbilt University189
+ 183 more
Also attended HBX | Harvard Business School142
+ 136 more
Shared employers
Also worked at National Institute of Environmental Health Sciences (NIEHS)1
Also worked at Washington University School of Medicine16
+ 10 more
Also worked at Vanderbilt University Medical Center6
Also worked at National Institutes of Health58
+ 52 more


























































